(Q51643799)

8 April 2018

title

TRALI after the infusion of marrow cells in a patient with acute lymphoblastic leukemia (English)

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00542.X

1 April 2024

1 reference

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00542.X

1 April 2024

9

Osamu Imataki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14617314

1 April 2024

author name string

Norinaga Urahama

1

1 reference

8 April 2018

Ryuji Tanosaki

2

1 reference

8 April 2018

Kami Masahiro

3

1 reference

8 April 2018

Kimiko Iijima

4

1 reference

8 April 2018

Aki Chizuka

5

1 reference

8 April 2018

Sung-Won Kim

6

1 reference

8 April 2018

Akiko Hori

7

1 reference

8 April 2018

Rie Kojima

8

1 reference

8 April 2018

Atsushi Makimito

10

1 reference

8 April 2018

Shin Mineishi

11

1 reference

8 April 2018

Yoichi Takaue

12

1 reference

8 April 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14617314

1 April 2024

publication date

1 November 2003

1 reference

8 April 2018

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1537-2995.2003.00542.x

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00542.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1537-2995.2003.00542.x

1 April 2024

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00542.X

1 April 2024

1 reference

8 April 2018

volume

43

1 reference

8 April 2018

issue

11

1 reference

8 April 2018

page(s)

1553-1557

1 reference

8 April 2018

Transfusion and lung injury

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00542.X

Diagnostic and pathogenetic considerations in transfusion-related acute lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00542.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00542.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00542.X

HLA class II antibodies in transfusion-related acute lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00542.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00542.X

Clinical risks for development of the acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00542.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00542.X

Recurrent transfusion-related acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00542.X

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00542.X

Detection of antineutrophil autoantibodies by flow cytometry: use of unfixed neutrophils as antigenic targets

1 April 2024

8

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00542.X

A microgranulocyte cytotoxicity test

1 April 2024

9

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00542.X

Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. The Consensus Committee

1 April 2024

10

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00542.X

Causes of mortality in patients with the adult respiratory distress syndrome

1 April 2024

11

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00542.X

Chronic autoimmune neutropenia due to anti-NA2 antibody

1 April 2024

13

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00542.X

1 April 2024

Granulocyte immunology

14

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00542.X

Specificities of anti-neutrophil autoantibodies in patients with rheumatoid arthritis (RA)

1 April 2024

15

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00542.X

Anti-neutrophil autoantibodies and systemic vasculitis: a report of five cases

1 April 2024

16

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00542.X

Anti-neutrophil antibodies in chronic hepatitis and the effect of alpha-interferon therapy

1 April 2024

17

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00542.X

Anti-neutrophil antibodies in chronic viral hepatitis

1 April 2024

18

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00542.X

Parvovirus B19 infection associated with the production of anti-neutrophil cytoplasmic antibody (ANCA) and anticardiolipin antibody (aCL).

1 April 2024

19

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00542.X

1 April 2024

Identifiers

1 reference

8 April 2018

1 reference

8 April 2018